Hookworm Disease

• CLINICAL_TRIALS trial_result · 2025-07-04
  Clinical Trial Update: Safety and Immunogenicity Study of Na-GST-1 With or Without CpG [Phase 1]

  Phase 1 safety and immunogenicity study of the Na-GST-1 hookworm vaccine with or without CpG adjuvant completed; results posted.

• FDA approval · 2021-09-20
  FDA Approved: VERMOX — Supplemental Application (Janssen Pharmaceuticals, Inc.)

  FDA issued a supplemental approval for Vermox (mebendazole) by Janssen Pharmaceuticals, expanding/updates its label.

• FDA approval · 2021-01-26
  FDA Approved: ALBENDAZOLE — Original Application (Dr.Reddys Laboratories Inc)

  FDA has approved Dr. Reddy's Laboratories Inc for albendazole under an Original Application, confirming the generic's authorization for list…

• CLINICAL_TRIALS trial_result · 2017-05-31
  Clinical Trial Update: Safety and Immunogenicity of Co-Administered Hookworm Vaccine Candidates Na-GST-1 and Na-APR-1 in Gabonese Adults [Phase 1]

  This Phase 1 study evaluates the safety and immunogenicity of co-administered Na-GST-1 and Na-APR-1 hookworm vaccine candidates in Gabonese …

• CLINICAL_TRIALS trial_result · 2017-05-31
  Clinical Trial Update: Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With or Without Additional Adjuvant in Brazilian Adults [Phase 1]

  Phase 1 clinical trial assessing the safety and immunogenicity of a human hookworm vaccine in Brazilian adults, with and without an addition…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2017-04-20
  Clinical Trial Update: Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With Different Doses of a Novel Adjuvant [Phase 1]

  Phase 1 trial evaluating safety and immunogenicity of a human hookworm vaccine candidate with different doses of a novel adjuvant; results h…